Neuroethics for the Neuroscience_Online
The present webinar series will address this gap by bringing together members from the neuroscience, medical, and psychiatry/psychology communities to translate basic science findings into real-world clinical practice. The proposed interdisciplinary planning committee will identify speakers with an established record of advancing clinical principles and techniques based on the basic science of emotion, socioemotional development, learning, memory, attention, and reward. Thus, the webinar series will identify areas of synergy on an interprofessional healthcare team based on complementary expertise and training backgrounds.
This program was designed for physicians, nurses, nurse practitioners, psychologists, and social workers.
Upon completion of this activity, participants should be able to:
- Evaluate promising neuroscientific findings in the areas of emotion, socioemotional learning and development, cognition, and therapeutic change that have significant potential to improve prevention and intervention efforts for mental illness.
- Recognize common barriers to the translation and adoption of basic science in real-world clinical practice.
- Articulate the benefits of integrating neuroscientific research in clinical practice in terms of prevention, assessment, and treatment for neuropsychiatric disorders.
Suggested Additional Reading
- Brief, E., & Illes, J. (2010). Tangles of neurogenetics, neuroethics, and culture. Neuron, 68(2), 174–177. https://doi.org/10.1016/j.neuron.2010.09.041
- Kaal, K. J., Harrison, M., Whitehurst, D., Townson, A., Dance, D., Stoessl, A. J., & Illes, J. (2018). Operationalizing Neuroimaging for Disorders of Consciousness in the Canadian Context. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 45(6), 633–635. https://doi.org/10.1017/cjn.2018.316
- Coates McCall, I., Minielly, N., Bethune, A., Lipsman, N., McDonald, P. J., & Illes, J. (2020). Readiness for First-In-Human Neuromodulatory Interventions. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 47(6), 785–792. https://doi.org/10.1017/cjn.2020.113
- Emerging Issues Task Force, International Neuroethics Society. (2019). Neuroethics at 15: The Current and Future Environment for Neuroethics. AJOB Neuroscience, 10(3), 104-110. Beauvais, M., Knoppers, B. M., & Illes, J. (2021). A marathon, not a sprint - neuroimaging, Open Science and ethics. NeuroImage, 236, 118041. Advance online publication. https://doi.org/10.1016/j.neuroimage.2021.118041
Judy Illes, CM, PhD.
Dr. Illes is Professor of Neurology and Canada Research Chair in Neuroethics at UBC. She is Director of Neuroethics Canada, and faculty in the Centre for Brain Health and at the Vancouver Coastal Health Research Institute. She received her PhD in Hearing and Speech Sciences, and in Neuropsychology at Stanford University, and became one of the pioneers of the field of neuroethics formally established in early 2000. Dr. Illes’ research, teaching and outreach initiatives are devoted to ethical, legal, social and policy challenges at the intersection of the brain sciences and biomedical ethics. She has made groundbreaking contributions to neuroethical thinking for neuroscience discovery and clinical translation specifically in the areas of neuroimaging, and neuromodulation across the lifespan, more broadly to entrepreneurship and the commercialization of health care. Dr. Illes is co-Lead of the Canadian Brain Research Strategy. She was elected to the Royal Society of Canada in 2012 and appointed to the Order of Canada in December 2017, the highest award for citizens in her country.
Angela Fang, PhD.
Greg Siegle, PhD.
Judy Callan, PhD, RN
Rudi De Raedt, PhD
Ryan Jane Jacoby, Ph.D.
Maria Kryza-Lacombe, PhD
Andrew Peckham, PhD
Michael Thase, MD
Conflict of Interest Disclosure:
Dr. Jacoby receives grant/research support from the National Institute of Mental Health under award number K23 MH120351. In the last year she has also received salary and research support from the International OCD Foundation, the Charles A. King Trust Postdoctoral Research Fellowship Program (Bank of America, N.A., Co-Trustees), the Harvard University Mind Brain Behavior Initiative, the Harvard University Department of Psychiatry Livingston Fellowship Award, and the Harvard University Pershing Square Fund for Research on the Foundations of Human Behavior. Dr. Jacoby has received salary support from Telefonica Alpha, Inc. She is paid as a faculty member of the Massachusetts General Hospital Psychiatry Academy. She also receives book royalties from Hogrefe Publishing.
Dr. Peckham receives research support from NIH, McLean Hospital and Harvard Medical School.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance